Evaxion A (EVAX) Interest & Investment Income (2020 - 2026)
Evaxion A (EVAX) posted Interest & Investment Income of $305000.0 for Q1 2026, down 51.28% on a QoQ basis from $626000.0 in Q4 2025, and down 87.77% year-over-year from $2.5 million in Q1 2025.
Evaxion A (EVAX) Interest & Investment Income (2020 - 2026) Analysis & Trends
Evaxion A's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $305000.0 for Q1 2026.
- Quarterly Interest & Investment Income fell 87.77% year-over-year to $305000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 61.24% YoY) and the FY2025 annual result came in at $6.4 million, down 2.23% from the prior year.
- Interest & Investment Income was $305000.0 for Q1 2026 at Evaxion A, down from $626000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $5.6 million in Q1 2024 and bottomed at $47000.0 in Q2 2023.
- A 5-year average of $1.1 million and a median of $559000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income plunged 96.95% — and 2025, when it surged 3102.38%.
- Evaxion A's Interest & Investment Income stood at $70000.0 in 2022, then surged by 698.57% to $559000.0 in 2023, then gained by 3.4% to $578000.0 in 2024, then climbed by 8.3% to $626000.0 in 2025, then sank by 51.28% to $305000.0 in 2026.
- Business Quant data shows EVAX's Interest & Investment Income at $305000.0 in Q1 2026, $626000.0 in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | 305,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 626,000.00 |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 578,000.00 |
| Sep 30, 2024 | 84,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 559,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 47,000.00 |
| Mar 31, 2023 | 285,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 703,000.00 |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 519,000.00 |
| Dec 31, 2021 | 746,000.00 |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.01 Mn |